As a fellow fan of Medipharm, this from the asset backing announcement on the 14th Dec, is a bit annoying
'With recent active portfolio management, through the on-market sale of some of the shares held in our public company investments in Harvest One and MediPharm Labs, we can now look forward to 2019 with a cash balance that is expected to provide us with more than a year of corporate working capital to fund our day-to-day operations.'
It couldn't have been many sold, but at least they were let go with some profit.